Search

everythinglearnresearchcommunity

for

Search:↓

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Women with excessive body hair often have higher male hormones and related health issues.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Ginger may help reduce testosterone and improve menstrual issues in women with PCOS.

Probiotics may help improve health markers in women with PCOS.

Early-onset hair loss in Egyptian males is linked to genetics, hormones, and lifestyle factors like smoking and diet.

Feminizing hormone therapy increases kidney filtration rate.

Testosterone is vital for male health, and its deficiency is linked to aging and common health issues.

Hormonal imbalances are important in the development of male pattern baldness.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.